Page 2 - Ivan Tornos News Today

The ROSA® Shoulder System Becomes the First-to-Market Robotic Surgical Assistant for Shoulder Arthroplasty and the Fourth ROSA Robotics Application in Five Years WARSAW, Ind., Feb. 22, 2024...

Zimmer Biomet earned FDA clearance for the Rosa Shoulder robot, the devicemaker said Feb. 22.

Zimmer Biomet (NYSE: ZBH) announced today that it received FDA 510(k) clearance for its Rosa Shoulder robotic assisted surgery system.

Orthobiologics represents a dynamic field within healthcare where the bodys natural healing mechanisms address osteoarthritis and enhance recovery from tendon and ligament injuries. These therapies...

Zimmer Biomet is laying off 3% of its workforce as part of a global restructuring that is expected to save the company $200 million by 2025, according to a stat

Fourth quarter net sales of $1.940 billion increased 6.3% and 6.1% on a constant currency1 basisFourth quarter diluted earnings per share were $2.01; adjusted1 diluted earnings per share were...

Company Sees Net Sales Increase and Provides Optimistic 2024 Guidance

Zimmer Biomet (NYSE: ZBH) shares slipped this morning despite fourth-quarter results that topped the consensus forecast.

Zimmer Biomet's Q4 2023 results, featuring 6.3% Y/Y net sales growth, $2.20 adjusted EPS, and a global restructuring plan for $200M cost savings.

"Discover the biggest shake-ups at Zimmer Biomet in 2023, from a new CEO appointment to biologics partnerships and record-breaking sales."